Monomeric Monocyte Chemoattractant Protein-1 (MCP-1) Binds and Activates the MCP-1 Receptor CCR2B*

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Biological Chemistry

• Publication date

  1998-12-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/JBC.273.50.33157PMID 9837883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new class of membrane-bound chemokine with a CX3C motif

  1997cited by this paper
• Glycosaminoglycans mediate cell surface oligomerization of chemokines.

  1997cited by this paper
• Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia

  1997cited by this paper
• An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model

  1997cited by this paper
• Arrangement of rhodopsin transmembrane alpha-helices.

  1997cited by this paper
• Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion

  1997cited by this paper
• Transcytosis and surface presentation of IL-8 by venular endothelial cells.

  1997cited by this paper
• Human chemokines: an update.

  1997cited by this paper
• Arrangement of rhodopsin transmembrane α-helices

  1997cited by this paper
• IL‐8 single‐chain homodimers and heterodimers: Interactions with the chemokine receptors CXCR1, CXCR2, and DARC

  1997cited by this paper
• Functional characterization of the C---C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2.

  1997cited by this paper
• Biological responses to C-C chemokines.

  1997cited by this paper
• Monomeric variants of IL‐8: Effects of side chain substitutions and solution conditions upon dimer formation

  1997cited by this paper
• Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

  1997cited by this paper
• Identification of a Glycosaminoglycan-binding Site in Chemokine Macrophage Inflammatory Protein-1α*

  1997cited by this paper
• Chemokines.

  1997cited by this paper
• Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis.

  1997cited by this paper
• Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

  1997cited by this paper
• Proline-dependent oligomerization with arm exchange.

  1997cited by this paper
• The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions

  1997cited by this paper
• The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

  1996cited by this paper
• The role of chemokines in inflammation

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• Identification of a major co-receptor for primary isolates of HIV-1

  1996cited by this paper
• Site-directed mutagenesis of monocyte chemoattractant protein-1 identifies two regions of the polypeptide essential for biological activity.

  1996cited by this paper
• Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer.

  1996cited by this paper
• Mutations in the B2 Bradykinin Receptor Reveal a Different Pattern of Contacts for Peptidic Agonists and Peptidic Antagonists*

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• Chemokine-leukocyte interactions. The voodoo that they do so well.

  1996cited by this paper
• Structural characterization of a monomeric chemokine: Monocyte chemoattractant protein‐3

  1996cited by this paper
• HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

  1996cited by this paper
• Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

  1995cited by this paper
• A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer

  1995cited by this paper
• Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)‐1β production by synovial T cells

  1995cited by this paper
• Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli.

  1995cited by this paper
• Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody.

  1995cited by this paper
• The three-dimensional solution structure of RANTES.

  1995cited by this paper
• Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

  1995cited by this paper
• ASSOCIATION OF BIOMOLECULAR SYSTEMS VIA PULSED FIELD GRADIENT NMR SELF-DIFFUSION MEASUREMENTS

  1995cited by this paper
• Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues

  1995cited by this paper
• 1H, 13C and 15N chemical shift referencing in biomolecular NMR

  1995cited by this paper
• Proton NMR assignments and solution conformation of RANTES, a chemokine of the C-C type.

  1995cited by this paper
• Three‐dimensional structures of α and β chemokines

  1995cited by this paper
• The solution structure of melanoma growth stimulating activity.

  1994cited by this paper
• Neutrophil activation by monomeric interleukin-8.

  1994cited by this paper
• Essential involvement of interleukin‐8 (IL‐8) in acute inflammation

  1994cited by this paper
• Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.

  1994cited by this paper
• The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations.

  1994cited by this paper
• High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR.

  1994cited by this paper
• Chemokines, leukocyte trafficking, and inflammation.

  1994cited by this paper
• The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.

  1994cited by this paper
• Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cells.

  1994cited by this paper
• Expression of the chemokine superfamily in rheumatoid arthritis

  1994cited by this paper
• Comparison of biological responses of human monocytes and THP‐1 cells to chemokines of the intercrine‐β family

  1994cited by this paper
• Structure and function of G protein-coupled receptors.

  1994cited by this paper
• Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

  1994cited by this paper
• Lymphotactin: a cytokine that represents a new class of chemokine.

  1994cited by this paper
• Neutrophil activation by monomeric interleukin-8

  1994cited by this paper
• The Importance of Not Saturating H2o in Protein NMR : application to Sensitivity Enhancement and Noe Measurements

  1993cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta.

  1993cited by this paper
• T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ

  1993cited by this paper
• Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines.

  1992cited by this paper
• Functional and structural studies of a small F-actin binding domain

  1992cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991cited by this paper
• Three-dimensional structure of interleukin 8 in solution.

  1991cited by this paper
• Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

  1991cited by this paper
• Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies.

  1991cited by this paper
• Monocyte chemoattractant protein-1 in human atheromatous plaques.

  1991cited by this paper
• Quantitative relationships between single-cell and cell-population model parameters for chemosensory migration responses of alveolar macrophages to C5a.

  1990cited by this paper
• Fermentation Development of Recombinant Pichia pastoris Expressing the Heterologous Gene: Bovine Lysozyme

  1990cited by this paper
• Calculation of protein extinction coefficients from amino acid sequence data.

  1989cited by this paper
• Measurement of leukocyte motility and chemotaxis parameters with the Millipore filter assay.

  1989cited by this paper
• Transport models for chemotactic cell populations based on individual cell behavior

  1989cited by this paper
• A new generation of Ca2+ indicators with greatly improved fluorescence properties.

  1985cited by this paper
• Culture Medium for Enterobacteria

  1974cited by this paper

• Discovery the Mechanism of Qingdi Mixture for Radiation‐Induced Lung Injury Based on Network Pharmacology, Clinical Retrospective Analysis and Experimental Validation

  2025cites this paper
• Effects of CCL2 chemokine missense mutations on CCR5 receptor affinity: a computational study in the context of HIV infection regulator discovery

  2025cites this paper
• Mechanism of Intervertebral Disc Degeneration via the β‐Catenin/CCL2 Pathway in Sox9 Conditional Knockout Mice

  2025cites this paper
• NMR Elucidation of Structure–Dynamics–Function Relationship of Engineered CCL2 Chemokine Monomer

  2025cites this paper
• Noncanonical roles of chemokine regions in CCR9 activation revealed by structural modeling and mutational mapping

  2024cites this paper
• Chemokine Oligomers and the Impact of Fondaparinux Binding

  2024cites this paper
• Multi-Algorithm-Integrated Tertiary Lymphoid Structure Gene Signature for Immune Landscape Characterization and Prognosis in Colorectal Cancer Patients

  2024cites this paper
• Exploring Chemokine Homodimer Stability: Structural Insights into CXC and CC Interfaces

  2024cites this paper
• Chemokine Heteromers and Their Impact on Cellular Function—A Conceptual Framework

  2023cites this paper
• Distinguish the Characteristic Mechanism of 3 Drug Pairs of Corydalis Rhizome in Ameliorating Angina Pectoris: Network Pharmacology and Meta-Analysis

  2023cites this paper
• Recruited macrophages elicit atrial fibrillation

  2023cites this paper
• Heterodimers Are an Integral Component of Chemokine Signaling Repertoire

  2023cites this paper
• CCL2 promotes osteogenesis by facilitating macrophage migration during acute inflammation

  2023cites this paper
• Epigenetics in migraine: A review

  2023cites this paper
• Single-Cell RNA-Seq Analysis Reveals Macrophages Are Involved in the Pathogenesis of Human Sporadic Acute Type A Aortic Dissection

  2023cites this paper
• Genome-wide identification, evolutionary analysis, and antimicrobial activity prediction of CC chemokines in allotetraploid common carp, Cyprinus carpio.

  2022cites this paper
• Migraine as an inflammatory disorder with microglial activation as a prime candidate

  2022cites this paper
• Maternal plasma cytokines and the subsequent risk of uterine atony and postpartum hemorrhage

  2022cites this paper
• Modeling OxLDL Epigenetic Innate Immune Training of Monocytes in Early Atherosclerotic Plaques

  2022cites this paper
• Expression of CCL2, FOS, and JUN May Help to Distinguish Patients With IgA Nephropathy From Healthy Controls

  2022cites this paper
• Entamoeba histolytica HM-1: IMSS gene expression profiling identifies key hub genes, potential biomarkers, and pathways in Amoebiasis infection: a systematic network meta-analysis

  2022cites this paper
• Hydroxyl Groups on Annular Ring-B Dictate the Affinities of Flavonol–CCL2 Chemokine Binding Interactions

  2021cites this paper
• The marriage of chemokines and galectins as functional heterodimers

  2021cites this paper
• The binding and specificity of chemokine binding proteins, through the lens of experiment and computation

  2021cites this paper
• The molecular structure and role of CCL2 (MCP‐1) and C‐C chemokine receptor CCR2 in skeletal biology and diseases

  2021cites this paper
• Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

  2021cites this paper
• Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis

  2021cites this paper
• OVERVIEW THE ADVANCED PATHOGENETIC THE OSTEOARTHRITIS

  2021cites this paper
• Chemokines and Bone.

  2020cites this paper
• Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses

  2020cites this paper
• Dissecting the differential structural and dynamics features of CCL2 chemokine orthologs.

  2020cites this paper
• Elucidating the Molecular Interactions of Chemokine CCL2 Orthologs with Flavonoid Baicalin

  2020cites this paper
• Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer’s disease risk

  2020cites this paper
• Targeting Chemokine—Glycosaminoglycan Interactions to Inhibit Inflammation

  2020cites this paper
• Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness

  2019cites this paper
• Fibrosis in Disease

  2019cites this paper
• Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1

  2018cites this paper
• Human CCL5 trimer: expression, purification and initial crystallographic studies.

  2018cites this paper
• Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1

  2018cites this paper
• Design, synthesis and characterisation of CCL2 constructs : selective delivery of fluorophores to monocytes

  2018influential citation
• The Role of Chemokines in Fibrotic Dermal Remodeling and Wound Healing

  2018cites this paper
• Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression

  2017cites this paper
• What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?

  2017cites this paper
• CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone

  2017influential citation
• Inflammatory Gene Expression in Whole Peripheral Blood at Early Stages of Sporadic Amyotrophic Lateral Sclerosis

  2017cites this paper
• Oligomerization State of CXCL4 Chemokines Regulates G Protein-Coupled Receptor Activation.

  2017cites this paper
• Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization

  2017cites this paper
• CCL2 nitration is a negative regulator of chemokine-mediated inflammation

  2017cites this paper
• Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System

  2017cites this paper
• Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein

  2017cites this paper
• Mechanisms of Regulation of the Chemokine-Receptor Network

  2017cites this paper
• Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3

  2016influential citation
• Chemokines and their receptors: insights from molecular modeling and crystallography.

  2016cites this paper
• New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

  2016cites this paper
• Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation.

  2016cites this paper
• The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization.

  2015cites this paper
• Bifurcation and dynamics in a mathematical model of early atherosclerosis

  2015cites this paper
• Chemokines and Bone

  2015cites this paper
• Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling.

  2015cites this paper
• Chemokines and microRNAs in atherosclerosis

  2015cites this paper
• Insights into the Role of Chemokines and Chemokine Receptors During HIV-1 Pathogenesis

  2015influential citation
• Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells

  2015cites this paper
• Mechanisms of Renal Graft Chronic Injury and Progression to Interstitial Fibrosis

  2015cites this paper
• Chemokine receptors CXCR4 and CCR5: Cell surface expression, signaling and modulation by β-arrestin 2

  2015cites this paper
• Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.

  2015cites this paper
• Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies

  2015cites this paper
• The Structure of a CXCR4:Chemokine Complex

  2015cites this paper
• Modulation of chemokine function during inflammation

  2014influential citation
• Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein

  2014cites this paper
• Monocyte chemoattractant protein-1 and the blood–brain barrier

  2014influential citation
• Multiple Glycosaminoglycan-binding Epitopes of Monocyte Chemoattractant Protein-3/CCL7 Enable It to Function as a Non-oligomerizing Chemokine*

  2014influential citation
• NMR characterization of cooperativity: fast ligand binding coupled to slow protein dimerization

  2014cites this paper
• Establishing the interaction between the CC chemokine ligand 5 and the receptors CCR1 and CCR5

  2014cites this paper
• Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer.

  2014cites this paper
• Role of 3D Structures in Understanding, Predicting, and Designing Molecular Interactions in the Chemokine Receptor Family

  2014cites this paper
• Chemokine Protein-3 / CCL 7 Enable It to Function as a Epitopes of Monocyte Chemoattractant Multiple Glycosaminoglycan-binding Molecular Biophysics :

  2014cites this paper
• CXCL12 chemokine and GABA neurotransmitter systems crosstalk and their putative roles

  2014cites this paper
• Identification of the Pharmacophore of the CC Chemokine-binding Proteins Evasin-1 and -4 Using Phage Display*

  2014cites this paper
• Impact of MCP-1 in atherosclerosis.

  2014cites this paper
• Monocyte chemoattractant protein‐1 is a mediator of the anabolic action of parathyroid hormone on bone

  2013cites this paper
• Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response.

  2013cites this paper
• MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma

  2013cites this paper
• Inside-out Signaling Promotes Dynamic Changes in the Carcinoembryonic Antigen-related Cellular Adhesion Molecule 1 (CEACAM1) Oligomeric State to Control Its Cell Adhesion Properties*

  2013cites this paper
• Chemokine oligomerization in cell signaling and migration.

  2013cites this paper
• Tyrosine Sulfation of Chemokine Receptor CCR2 Enhances Interactions with Both Monomeric and Dimeric Forms of the Chemokine Monocyte Chemoattractant Protein-1 (MCP-1)*

  2013cites this paper
• Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

  2013cites this paper
• Evaluation of two cyclic di-peptides as inhibitors of CCL2 induced chemotaxis

  2013cites this paper
• Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration.

  2012cites this paper
• Chemokines and Their Receptors as Therapeutic Targets in Atherosclerosis

  2012cites this paper
• Properties of 7ND-CCL2 are modulated upon fusion to Fc.

  2012cites this paper
• Loss of the Lipopolysaccharide Core Biosynthesis rfaD Gene Increases Antimicrobial Chemokine Binding and Bacterial Susceptibility to CCL28 and Polymyxin: A Model for Understanding the Interface of Antimicrobial Chemokines and Bacterial Host Defense Avoidance Mechanisms

  2012cites this paper
• Design and Receptor Interactions of Obligate Dimeric Mutant of Chemokine Monocyte Chemoattractant Protein-1 (MCP-1)*

  2012influential citation
• Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888.

  2012cites this paper
• Exploration de nouvelles approches pour les études de RCPG au niveau moléculaire : application aux récepteurs de chimiokines

  2012cites this paper
• A truncated analogue of CCL2 mediates anti-fibrotic effects on murine fibroblasts independently of CCR2.

  2012cites this paper
• Structure‐based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans

  2012cites this paper
• Protein structural investigation using hydroxyl radical protein footprinting

  2012cites this paper
• Synthetic peptide fragment (65–76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting

  2011cites this paper
• New G-protein-coupled receptor structures provide insights into the recognition of CXCL12 and HIV-1 gp120 by CXCR4.

  2011cites this paper
• Structural Aspects of Chemokines and Their Interactions with Receptors and Glycosaminoglycans

  2011cites this paper